Jove
Visualize
Contact Us

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

60.3K
Overview
60.3K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

435
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
435
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.5K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

201
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
201
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agent-based modeling demonstrates how target-independent processes supplement killing by antibody-drug conjugates in cancer therapy.

PLoS computational biology·2026
Same author

The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomas.

Nature immunology·2026
Same author

In Vivo Auto-tuning of Antibody-Drug Conjugate Delivery to Maximize Efficacy Using High-Avidity, Low-Affinity Antibodies.

Molecular cancer therapeutics·2025
Same author

Local traveling waves of cytosolic Ca<sup>2+</sup> elicited by defense signals or wounding are propagated by distinct mechanisms in <i>Arabidopsis</i>.

Science signaling·2025
Same author

Rules of life at the interface of calcium signaling and mechanobiology.

APL bioengineering·2025
Same author

Inference of weak-form partial differential equations describing migration and proliferation mechanisms in wound healing experiments on cancer cells.

PLoS computational biology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 16, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Applying optimization algorithms to tuberculosis antibiotic treatment regimens.

Joseph M Cicchese1, Elsje Pienaar1,2, Denise E Kirschner2

  • 1Department of Chemical Engineering, University of Michigan, 2800 Plymouth Rd, NCRC B28, Ann Arbor, MI, 48109-2800.

Cellular and Molecular Bioengineering
|December 26, 2017
PubMed
Summary
This summary is machine-generated.

Optimizing tuberculosis (TB) treatment regimens is crucial for combating drug resistance. Surrogate-assisted optimization using radial basis function networks offers a practical approach to finding effective multi-drug strategies with fewer simulations.

Keywords:
agent-based modelingantibioticsgenetic algorithmsurrogate-assisted optimizationtuberculosis

More Related Videos

Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment
09:25

Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment

Published on: February 22, 2017

8.0K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K

Related Experiment Videos

Last Updated: Feb 16, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K
Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment
09:25

Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment

Published on: February 22, 2017

8.0K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K

Area of Science:

  • Computational biology
  • Mathematical modeling
  • Pharmacology

Background:

  • Tuberculosis (TB) treatment requires lengthy multi-antibiotic regimens, leading to poor adherence and multi-drug resistant TB.
  • The vast search space of potential antibiotic combinations, doses, and schedules hinders the development of new TB treatment strategies.

Purpose of the Study:

  • To develop and evaluate a computational method combining agent-based modeling and mathematical optimization for identifying optimal TB treatment regimens.
  • To compare the efficacy of genetic algorithms (GA) and surrogate-assisted optimization with radial basis function (RBF) networks in predicting optimal treatment strategies.

Main Methods:

  • An agent-based multi-scale model of TB granuloma formation was integrated with optimization algorithms.
  • Genetic algorithms (GA) and RBF network-based surrogate-assisted optimization were employed to identify optimal single- and double-antibiotic regimens.
  • The efficiency and accuracy of GA and RBF networks were compared using single-antibiotic treatments.

Main Results:

  • While GAs achieved higher accuracy in locating optimal regimens, RBF networks demonstrated greater practicality by requiring fewer simulations.
  • RBF networks successfully estimated optimal double-antibiotic treatment regimens.
  • Surrogate-assisted optimization proved effective in navigating the complex regimen design space.

Conclusions:

  • Surrogate-assisted optimization, particularly using RBF networks, provides an efficient method for identifying optimal TB treatment regimens from a vast array of possibilities.
  • This approach has significant implications for optimizing treatments for TB and other complex diseases requiring multi-drug therapies.
  • The methodology can be extended to address optimization challenges in diverse research areas employing systems biology.